RegCell
Developer of autoimmune drugs intended to provide medical care for autoimmune diseases and cancer. The company utilizes research protocol that involves regulating control T cells to proliferate and ac...
Valuation
$0
Share Price
N/A
Total Raised
$63.9M
Last Round
N/A